Friday, July 21, 2017 11:03:58 AM
For now, the sales of Cupridyne will get us up to $5 within six months, helped by the filing and acceptance with the FDA for Clyra. All things point to the success of this company. Clyra is the real deal, as presented by Dr. Liden at the conference in Puerto Rico a couple weeks ago. The filing will be any day now, and it is only a 180-day turnaround.
The three purchasing agreements for Cupridyne are a great endorsement wave. They are vendor qualifications which validate our ablity to supply our product, and which show that the company demos worked. Each large waste company executive heralded Cupri as a game-changer. Huge companies. If we get only 20% of the odor-control market, we make $30-40M a year, and that is conservative. Just on Cupri. And it is a done deal in terms of the biggest players raving about it. We will probably get over 50% of the odor market, and in more than just the waste beds.
Stay tuned for what is going on with Carrollo Engineering. The 10Q for 2017 Q1 says they are cooking, and makes reference to things still being monitored and ready to roll with CB&I (or Veritas, the new group that bought our branch of CB&I. That will put AOS back on track.
Only the meek would not be adding at any price less than $1.50 these days.
Recent BLGO News
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 01/23/2024 02:27:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 03:15:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 05:12:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 06:05:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 01:03:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:05:53 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 11:17:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 10:42:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2023 11:01:23 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 06:28:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 05:33:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 10:20:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 10:19:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 10:18:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 10:17:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 10:08:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:57:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2023 10:55:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2023 05:10:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:51:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:45:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:23:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:07:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:00:31 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM